We have studied the interactions of five indolocarbazoles with N- [methyl-3 H]scopolamine (NMS) and unlabeled acetylcholine at M 1 -M 4 muscarinic receptors, using equilibrium and nonequilibrium radioligand binding studies. The results are consistent with an allosteric model in which the primary and allosteric ligands bind simultaneously to the receptor and modify each other's affinities. The compounds were generally most active at M 1 receptors. [
M in assays containing unlabeled ACh. Data points were usually measured in duplicate. CHO cell membranes do not possess cholinesterase activity (Gnagey and Ellis, 1996; Lazareno and Birdsall, 1993) , so ACh could be used in the absence of a cholinesterase inhibitor. The indolocarbazoles and brucine were dissolved in dimethyl sulfoxide, which, at the highest final concentration of 2%, had no effect on binding.
Experimental Designs and Data Analysis. General data preprocessing, as well as the affinity ratio calculations and routine plots of the semiquantitative equilibrium assay, were performed using Minitab (Minitab, Coventry, UK). The other assays were evaluated by nonlinear regression analysis, using the fitting procedure in SigmaPlot (SPSS, Erkrath, Germany). This procedure is relatively powerful in that it allows the use of two or more independent variables, e.g., concentrations of two drugs.
Equilibrium Binding Assays for Estimation of the Affinity of an Allosteric Agent for the Receptor and the Magnitude of its Cooperativity with [
3 H]NMS and ACh. The design and analyses have been described in detail (Lazareno and Birdsall, 1995; Lazareno et al., 1998) . Briefly, specific binding of a low concentration of [ 3 H]NMS (one to two times the K d ) was measured in the presence of a number of concentrations of test agent, all in the absence and presence of one or more concentrations of ACh. Specific binding of a high concentration of [ 3 H]NMS (5-10 times K d ) was also measured. Nonlinear regression analysis was used to fit the data to the equation
where B LAX is the observed specific bound radioligand; L, A, and X are concentrations of [ 3 H]NMS, ACh, and allosteric agent, respectively, K L , K A , and K X are affinity constants for the corresponding ligands and the receptor, ␣ and ␤ are allosteric constants of X with [ 3 H]NMS and ACh respectively, n is a logistic slope factor that describes the binding of ACh, and s is a Schild slope factor that describes the binding of X. According to the allosteric model s should be 1. K d values (pM) for [ 3 H]NMS from these assays were 136 Ϯ 4, n ϭ 24; 481 Ϯ 33, n ϭ 15; 262 Ϯ 23, n ϭ 14; and 134 Ϯ 5, n ϭ 13, corresponding to log affinity (M Ϫ1 ) values of 9.87, 9.32, 9.58, and 9.87 at M 1 -M 4 receptors, respectively.
Above a certain concentration, some allosteric agents, especially those that exhibit neutral or positive cooperativity with [ 3 H]NMS, may slow the kinetics of [ 3 H]NMS binding so much that the binding does not reach equilibrium. In most cases sufficient incubation time was used to allow [ 3 H]NMS binding in the presence of the agent to reach equilibrium. In a few cases, however, the highest concentration of agent would be predicted to slow [ 3 H]NMS kinetics sufficiently to prevent binding equilibrium from being reached, and in these cases the data were better fitted to the equation
where B LAXt is the observed specific binding under nonequilibrium conditions, B LAX is the predicted equilibrium binding defined in eq. 1, t is the incubation time, k off is the dissociation rate constant of [ 3 H]NMS, and B LO is the initial amount of bound radioligand, set to zero in this case. This equation assumes that the dissociation of [ 3 H]NMS from the allosteric agent-occupied receptor is negligible, and that the binding kinetics of both ACh and the allosteric agent are fast in comparison with the dissociation rate of [ 3 H]NMS. If only a single concentration of ACh was used, the data were visualized with affinity ratio plots, where the affinity ratio is the apparent affinity of the primary ligand ([ 3 H]NMS or ACh) in the presence of a particular concentration of test agent divided by the apparent affinity of the primary ligand in the absence of test agent. Theoretically, the EC 50 or IC 50 of the affinity ratio plot corresponds to the K d of the test agent at the free receptor, and the asymptotic level corresponds to the cooperativity constant for the test agent and primary ligand (Lazareno and Birdsall, 1995) . Affinity ratios were calculated from the specific binding data as follows (Lazareno and Birdsall, 1999 
The affinity ratio of ACh in the presence of a single concentration of test agent is
where With assays containing a number of ACh concentrations, affinity ratio plots were calculated using the parameter estimates from the fit of the data set to eq. 1 or 2 as appropriate (Lazareno and Birdsall, 1995) .
The affinity ratios of [ 3 H]NMS and ACh, r L and r A , respectively, are
and
where the symbols are as described above.
Off-Rate Assay to Estimate the Affinity of an Allosteric Agent for the [
3 H]NMS-Occupied Receptor. A high concentration of membranes (2-4 mg protein/ml) was incubated with a high concentration of [ 3 H]NMS (5 nM) for about 15 min. Then 10-l aliquots were distributed to tubes that were empty or contained 1 ml of 10 Ϫ6 M QNB alone and in the presence of a number of concentrations of allosteric agent (typically n ϭ 4). Nonspecific binding was measured in separately prepared tubes containing 10 l of membrane and 2 l of [ 3 H]NMS ϩ QNB. Some time later, after about 2.5 dissociation halfϪlives (see Table 2 ), the samples were filtered. The data were transformed to rate constants, k off , using the formula
where B 0 is initially bound radioligand and B t is bound radioligand remaining after t min of dissociation. (Lazareno and Birdsall, 1995) . Initially the curve was fitted without constraints. If the slope factor was not different from 1, and the maximum inhibition (E max ) did not exceed about 100%, then the slope was constrained to 1 and the E max was fitted. If the fitted E max exceeded 100% (a physical impossibility, apart from experimental variation or error), then the E max was constrained to 100 and the slope was fitted. With the compounds under study the E max was often less than 100, and in most such cases the data were well fitted with the slope constrained to 1. GTP␥S Binding Assay. Membranes expressing M 1 receptors (5-20 g/ml) were incubated with [
35 S]GTP␥S (0.1 nM), GDP (10 Ϫ7 M), and ligands in incubation buffer in a volume of l ml for 30-60 min at 30°C. Bound label was collected by filtration over glass fiber filters prewetted with water.
Results
The structures of the compounds examined are shown in Fig. 1 . Figure 2 shows (Lazareno and Birdsall, 1995) . The effect of staurosporine on ACh binding is not clear from inspection of Fig. 2 , but nonlinear regression analysis of the data, which also takes into account the effects of high concentrations of staurosporine on the kinetics of [ alize when the binding data are transformed into affinity ratios (Lazareno and Birdsall, 1995; Lazareno et al., 1998) (Fig. 3) (Fig. 3) . It was necessary to introduce a slope factor Ͼ1 into the binding equation for Gö 7874 to fit the data adequately to the allosteric model (Table 1) . Gö 7874 caused apparently complete inhibition of [ 3 H]NMS dissociation at M 1 , M 2 , and M 4 receptors and submaximum inhibition at M 3 receptors. The slopes of the curves at M 1 , M 2 , and M 4 receptors were also greater than 1 (Fig. 4 and Table 2 ). The ternary complex allosteric model does not predict slope factors different from 1, so it cannot provide a complete mechanistic explanation of these data. Nevertheless, the affinity values of Gö 7874 for the [ 3 H]NMS-occupied receptor predicted by the model from the equilibrium binding studies are in excellent agreement with the observed values at M 1 and M 4 receptors (Table 2 ) and show only a three-fold discrepancy at M 2 and M 3 receptors, possibly caused by a combination of inaccuracies in the measurement of the small cooperative effects that occurred in equilibrium studies at the M 2 and M 3 subtypes (Table 1) (Fig. 4) (Fig. 3) , whereas a later batch had small M 3 , and M 4 receptors, with little or no effect at M 2 receptors (again, earlier batches showed no effect at M 2 receptors, whereas a later batch showed a small inhibition (Fig. 4) ). The largest effect was seen with M 1 receptors, and, at this subtype alone, low concentrations of KT5720 caused a small but consistent increase in [ 3 H]NMS dissociation. This phenomenon was observed in 10 of 11 single-time point assays, with the dissociation rate constant (k off ) of [ 3 H]NMS increased by 11 Ϯ 1% (n ϭ 10) in the presence of the most effective concentration between 10 and 300 nM KT5720, and in two full time-course studies in which k off in the presence of 0.1 M KT5720 was increased by 16.3 Ϯ 0.5 % (data not shown). The affinity of KT5720 for the [ 3 H]NMS-occupied receptor estimated from equilibrium studies at M 1 and M 4 receptors was similar to the values measured directly (Table 2) . K-252a, in which the methoxy group of KT5823 is replaced by a hydroxyl group, showed positive cooperativity with [ 3 H]NMS at M 1 receptors and neutral or small negative cooperativity with ACh ( Fig. 3 and Table 1 ). Little or no effect was seen in equilibrium binding studies with the other subtypes. K-252a inhibited [ 3 H]NMS dissociation at M 1 receptors, apparently by 100%. Slope factors greater than 1 were required to fit the data adequately. Only small, though consistent, effects on the [ 3 H]NMS off-rate were seen at the other subtypes (Fig. 4 and Table 2) .
K-252b, K-252c, KT-5926, and Gö 6976 at concentrations up to 10 M had little or no effect on equilibrium binding of We have attempted to determine whether some of the allosteric effects described above occurred through an interaction at the same site on the receptor at which other known allosteric agents act. Figure 6A shows the interaction between KT5720 and gallamine on equilibrium [
3 H]NMS binding at M 1 receptors. Gallamine had its expected inhibitory effect on [ 3 H]NMS binding, and KT5720 showed the expected positive cooperativity with [ 3 H]NMS. If gallamine and KT5720 were acting at the same site, then gallamine should have become less potent in the presence of KT5720 and the nonlinear regression analysis would have indicated strong negative cooperativity between the two agents. In fact, the analysis revealed neutral cooperativity, i.e., in equilibrium binding studies gallamine and KT5720 interact allosterically at M 1 receptors through distinct and apparently noninteracting sites. In similar experiments with staurosporine and gallamine at M 1 receptors, however, there was a negatively cooperative or competitive interaction between the compounds (Fig. 6B) .
To study the site(s) on the M 1 receptor at which KT5720 acts to affect [ 3 H]NMS dissociation, the concentration-related effect of KT5720 was measured alone and in the presence of two or three concentrations each of gallamine, brucine, and staurosporine. Very similar results were obtained in two independent assays; the combined data are shown in Fig. 7 . The data in each condition are shown in two forms: as a percentage inhibition of the overall control (i.e., true) k off measured in the absence of any test agent and, for each curve, as a fraction of its own control k off measured in the presence of the test agent and the absence of KT5720. This latter fractional effect measure has useful properties: if the interaction between KT5720 and the test agent is competi- Fig. 4 . Effect of five compounds on the dissociation rate constant (k off ) of [tive, then in the presence of the test agent the EC 50 will increase and the asymptotic fractional effect will also change; if the interaction is noncompetitive and noninteracting (i.e., with neutral cooperativity), and if maximum concentrations of test agent completely inhibit [ 3 H]NMS dissociation, then in the presence of the test agent both the EC 50 and asymptotic levels are unchanged (see the Appendix).
Allosterism of Indolocarbazoles at Muscarinic Receptors
The lines in the top row of Fig. 7 (except in the presence of staurosporine) are hyperbolic fits to the data. The effect of low concentrations of KT5720 of increasing [ 3 H]NMS dissociation was apparent in all of the curves. When the data are expressed as a fractional effect of own control, the curves for KT5720 in the presence of various concentrations of gallamine or brucine overlap, i.e., they have the same EC 50 and asymptotic level. There was a small concentration-related increase in potency in the presence of gallamine, but this is probably experimental noise, because a positively cooperative interaction would result in decreases in the asymptotic level of the fraction of own control plots. These data therefore demonstrate that KT5720 acts at a site different from those at which gallamine and brucine act to inhibit [ 3 H]NMS dissociation from M 1 receptors.
A quite different pattern of results was seen with staurosporine. The stimulating effect of low concentrations of KT5720 became more apparent, and the curves tend to converge at high concentrations of KT5720 more than in the presence of gallamine or brucine. It was not possible to measure EC 50 values accurately, but inspection of the fractional effect plot suggests that staurosporine reduced the potency of KT5720. These results may indicate that staurosporine and KT5720 compete for the site that mediates inhibition of [ 3 H]NMS dissociation. They strongly suggest that staurosporine can act at site(s) different from those of gallamine or brucine.
Discussion
Five of the nine indolocarbazoles that we have studied act allosterically at muscarinic receptors. Of these, four have similar structures and a number of similarities in their allosteric effects, whereas the fifth, Gö 7874, lacks the tetrahydrofuran/pyran ring system, which may account for its somewhat different effects.
In equilibrium binding studies the four active staurosporine-like compounds (staurosporine, KT5823, KT5720, and K-252a) showed only positive or neutral cooperativity with [ 3 H]NMS, or were apparently inactive, whereas positive, neutral, and negative cooperativity was observed with ACh. The four compounds showed their highest affinity and largest positive effects with [ 3 H]NMS, at the M 1 receptor, whereas they were inactive (or neutrally cooperative with [ 3 H]NMS and ACh) at M 3 receptors. These compounds bound with slope factors of 1, except for KT5823 at M 1 receptors, and this exception may be partly accounted for by artefacts arising from the strong (7-10-fold) positive cooperativity with [
3 H]NMS seen with this compound. Gö 7874, the other positively charged ligand in addition to staurosporine, also showed selectivity for the M 1 receptor, but, in contrast to the other four compounds, it showed negative cooperativity with [ 3 H]NMS and both neutral and negative cooperativity with ACh, and it bound with slope factors greater than 1.
The four staurosporine-like compounds also showed selectivity for the The estd pK is the product of affinity for the free receptor and cooperativity with [ 3 H]NMS derived from the equilibrium binding assays summarized in Table 1 . diff is the difference between the observed pK (-log IC 50 ) and estd pK. The results are from at least three assays, except for *n ϭ 2. Empty cells indicate that it was not possible to obtain at least two sets of parameter estimates. The 3 H]NMS, measured at equilibrium. In this study there are 11 instances where these measures have been determined with sufficient precision to allow comparison. There was good agreement between the measures: three comparisons differed by about threefold, one by about twofold, and the rest (seven) by 60% or less, and there was no obvious bias, because in five cases the equilibrium estimate was larger than the directly measured value and in seven cases it was smaller. These results suggest that the data can be accounted for by the allosteric model, even The points are the mean and range/2 of duplicate observations. The lines show the fit to eq. 1 with the slope factor for KT5720 binding set to 1. The parameter estimates were log affinity of KT5720, 6.6 Ϯ 0.1; cooperativity with [ 3 H]NMS, 1.9 Ϯ 0.1; cooperativity with ACh, 1.6 Ϯ 0.2. The inset shows affinity ratio plots derived from these parameters (see Experimental Procedures). The -log IC 50 values of ACh in the presence of increasing concentrations of KT5720, from independent logistic fits of the curves, were 5.28, 5.33, 5.40, and 5.42.
Fig. 6. Inhibition by gallamine of [
3 H]NMS binding at M 1 receptors in the presence of various concentrations of (A) KT5720 and (B) staurosporine. The points are individual observations. The lines show the fit of the data to eq. 9 (see Appendix), where the cooperativity estimates of gallamine with KT5720 and staurosporine were not significantly different from 1 and 0, respectively, and were set to those values. The slope factors for gallamine, KT5720, and staurosporine were not different from 1 and were set at that value. From three such assays, similarly constrained, KT5720 had a log affinity of 6.22 Ϯ 0.17 and a cooperativity with [ though the steep slopes seen with Gö 7874 and K-252a are not predicted by the model.
The simple model also cannot account for the effects of KT5720 on [ 3 H]NMS dissociation at M 1 receptors, with an initial speeding of dissociation by about 15% at submicromolar concentrations, followed by submaximum inhibition of dissociation at higher concentrations. In the presence of staurosporine the speeding effect became more prominent, whereas the potency of KT5720 for slowing [ 3 H]NMS dissociation appeared to be reduced, suggesting that KT5720 may be exerting its effects at two distinct sites, only one of which can also be occupied by staurosporine. In contrast, the presence of gallamine or brucine had no effect on the potency of KT5270 or its fractional asymptotic effect, suggesting that, unlike staurosporine, gallamine and brucine act at a site different from the site(s) at which KT5720 modulates [ 3 H]NMS dissociation, and that there is no interaction (i.e., neutral cooperativity) between the binding of KT5270 and that of brucine or gallamine.
A similar conclusion can be drawn from equilibrium binding studies at M 1 receptors, in which KT5720 showed no interaction with gallamine. In contrast, similar equilibrium binding studies at M 1 receptors with staurosporine and gallamine revealed a negatively cooperative or competitive interaction. If the interaction between gallamine and staurosporine is truly competitive, this would imply that bound staurosporine occludes both the gallamine and the KT5720 site. A more parsimonious explanation is that staurosporine binds to the KT5720 site and has negative cooperativity with gallamine. The different interactions with gallamine shown by staurosporine (negative) and KT5720 (neutral) may be related to the fact that staurosporine, like gallamine, is a positively charged molecule, whereas KT5720 is neutral.
These results demonstrate that KT5720, and possibly other indolocarbazoles, bind to an allosteric site on muscarinic receptors that is distinct from the common allosteric site to which gallamine and most other allosteric agents bind. Previously reported allosteric agents have a positively charged nitrogen that is thought to be important for their action. Staurosporine and Gö 7874 are also positively charged, but the other active indolocarbazoles are neutral, which suggests that there is no necessity for a positively charged nitrogen at this new allosteric site. The observed affinities and cooperativities are sensitive to small changes in the chemical structure of the analogs. For example, increasing the alkyl chain length of the ester function of K-252a or methylation of its hydroxyl group increases affinity by molpharm.aspetjournals.org 3-15-fold, whereas removal of the methyl group on the ester of K-252a or the alkoxy substitution of the indolocarbazole ring generate apparently inactive compounds.
The agents studied here are known to be potent inhibitors of various protein kinases (Tamaoki et al., 1986; Kase et al., 1987; Kleinschroth et al., 1995) , and in most cases the agents have much higher affinity for these targets than for muscarinic receptors, but it is worth noting that KT5720 has only about a sixfold higher potency for its preferred target, protein kinase A (PKA), than for the M 1 receptor (log affinity of 7.2 at PKA versus 6.4 at M 1 receptors; Kase et al., 1987) .
One of our aims has been the development of drugs that enhance the affinity of ACh at M 1 receptors while having no effect on ACh binding and function at the other subtypes. The detection of the allosteric properties of KT5720 may be a step toward that goal. KT5720 was the most potent compound at M 1 receptors with a log affinity for the free receptor of 6.4, and it showed a small (40%) but consistent positive cooperative effect with ACh. In addition, it may have had little or no effect on ACh affinity at the other subtypes, so KT5720 is close to displaying an absolute subtype selectivity for the M 1 receptor, i.e., a positive or negative interaction with ACh at one receptor subtype and neutral cooperativity at the others, so that whatever concentration of agent is administered, only the one receptor subtype is affected functionally (Lazareno and Birdsall, 1995) .
In conclusion, we have detected quite potent allosteric interactions of staurosporine and some other indolocarbazole analogs at muscarinic receptors that, at least in the case of KT5720, occur at a site distinct from the common allosteric site. The active indolocarbazoles cause different maximum effects on [ 3 H]NMS dissociation, and the size of the maximum effect on [ 3 H]NMS dissociation is a good predictor of the activity detected in equilibrium studies, suggesting a common mechanism for the two effects. In general, the results from equilibrium and dissociation assays were mutually consistent with the ternary allosteric complex model as the underlying mechanism of the observed effects, but the steep binding slopes seen with two of the compounds and the complex effects of KT5720 on Total receptor concentration is
Bound radioligand as a fraction of total receptor is
The apparent affinity of L in the presence of X and Y is
Kinetic Effects on Equilibrium Binding
To estimate the apparent association rate constant in the presence of X and Y, k obsXY , we start with the simple definition for radioligand alone:
This relationship should be general as long as dissociation kinetics are monoexponential, so
(see eq. 11 for the definition of k offobsXY ), and the bound at time t is therefore
Kinetic Effects of Two Allosteric Agents on Radioligand k off
Here we consider the binding of two agents to the radioligand-occupied receptor. We assume that the allosteric agents have rapid kinetics compared to the radioligand k off and that there may be cooperative effects between the agents.
Assume that each agent, X and Y, can bind to a different site on the radioligand-occupied receptor, with affinities of K Xo and K Yo , respectively (ϭ ␣ ⅐ K X and ␤ ⅐ K Y , respectively), and with cooperativity ␦. If ␦ ϭ 0, then the interaction behaves as though X and Y are competitive with each other. If ␦ ϭ 1, then the binding of X and Y is noninteracting. k off is the dissociation rate constant of L from LR; is the ratio of the dissociation rate constants of L from the occupied and free receptor, i.e., B LXY is the bound radioligand in the presence of X and Y at any dissociation time, assuming rapid kinetics.
Let p, q, and r correspond to the proportion of L-occupied receptors containing X alone, Y alone, and both X and Y, respectively. The remaining portion of L-occupied receptors, 1 Ϫ p Ϫ q Ϫ r, has no allosteric agent bound. The observed off-rate in the presence of X and Y, k offobsXY , is given by
We can make the simplifying assumption that Y ϭ 0 (in the current experiments Y corresponds to gallamine, strychnine, or staurosporine, all of which appear to block completely the dissociation of [ 3 H]NMS at M 1 receptors). We also assume that the off-rate from the dually occupied receptor is 0 ( XY ϭ 0). In this case,
Now we consider the effect of a fixed concentration of Y on the parameters of concentration-effect curves of X and the observed radioligand dissociation rate constant. The Effect of Y on the EC 50 of X. From eq. 11, when X ϭ 0,
when X 3 ϱ,
The fractional effect of intermediate concentrations of X is
This equation has the form X ⅐ K app /(1 ϩ X ⅐ K app ), where K app is 1/EC 50 . The EC 50 of X in the presence of Y is therefore
The EC 50 of X in the absence of Y is
The dose ratio produced by a particular concentration of Y on the EC 50 of X is
The concentration of Y causing half the maximum dose ratio is 1/͑K Yo ⅐ ␦).
The maximum dose ratio, as Y 3 ϱ, is 1/␦. The Effect of Y on the Efmax of X. Define Ef XY , the k offobs with varying concentrations of X in the presence of a fixed concentration of Y as a fraction of the k offobs with the same concentration of Y alone:
Efmax XY , the maximum value of Ef XY as X 3 ϱ, is
The Efmax in the absence of Y is Efmax X ϭ X (20) 
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The change in Efmax of X as a function of Y may be expressed as the ratio
This is equal to the dose ratio produced by Y on the EC 50 of X (eq 17) and similarly has a maximum value of 1/␦ as Y 3 ϱ, with a half-maximum value when Y ϭ 1/(K Yo ⅐ ␦). In summary, for concentration-effect curves of X on E f XY (the k offobs in the presence of X and Y expressed as a fraction of the k offobs in the presence of Y alone), if the radioligand cannot dissociate from Y-occupied receptors ( Y ϭ 0 and XY ϭ 0), then Y has the same fractional effect on EC 50XY and Efmax XY , with a limiting value of 1/␦, where ␦ is the cooperativity between X and Y. If ␦ ϭ 0, then the interaction between X and Y is competitive, and there is no limiting effect of Y. If ␦ ϭ 1, then the curves of Ef XY versus [X] in the presence of any concentration of Y are superimposable.
